This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by da Silva Tatley, F.
Right arrow Articles by Guilford, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by da Silva Tatley, F.
Right arrow Articles by Guilford, P. J.

 Previous Article  |  Next Article 

Infection and Immunity, March 2003, p. 1580-1583, Vol. 71, No. 3
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.3.1580-1583.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

N-Terminal E-Cadherin Peptides Act as Decoy Receptors for Listeria monocytogenes

Fernanda da Silva Tatley,1,2 Frank E. Aldwell,2 Anita K. Dunbier,1 and Parry J. Guilford1*

Cancer Genetics Laboratory, Department of Biochemistry,1 Department of Microbiology, University of Otago, Dunedin, Aotearoa, New Zealand2

Received 5 August 2002/ Returned for modification 30 September 2002/ Accepted 2 December 2002

The observation that E-cadherin is the principal epithelial receptor for the bacterial pathogen Listeria monocytogenes led us to investigate whether N-terminal fragments of E-cadherin containing the L. monocytogenes binding domain could inhibit entry of the bacteria into cultured epithelial cells. Here we demonstrate that a conditioned medium from a gastric cancer cell line (Kato III) that carries a truncating CDH-1 mutation 3' of the L. monocytogenes binding domain can inhibit the uptake of the bacteria into Caco-2 cells. The inhibitory activity of the Kato III conditioned medium could be mimicked by incubation of the bacteria with a recombinant 26-kDa N-terminal E-cadherin peptide prior to infection. Furthermore, these data suggest that cleavage of the 80-kDa extracellular domain of E-cadherin from the cell surface may provide an innate form of pathogen defense by acting as a decoy receptor for L. monocytogenes.


* Corresponding author. Mailing address: Cancer Genetics Laboratory, Department of Biochemistry, University of Otago, P.O. Box 56, Dunedin, New Zealand. Phone: 64-3-4795803. Fax: 64-3-479580. E-mail: parry.guilford{at}otago.ac.nz.

Editor: J. T. Barbieri


Infection and Immunity, March 2003, p. 1580-1583, Vol. 71, No. 3
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.3.1580-1583.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Sahu, S. C., Gaines, D. W., Williams, K. M., Raybourne, R. B. (2007). A synthetic polypeptide based on human E-cadherin inhibits invasion of human intestinal and liver cell lines by Listeria monocytogenes. J Med Microbiol 56: 1011-1016 [Abstract] [Full Text]  
  • De Paul, A. L., Bonaterra, M., Soler, A. P., Knudsen, K. A., Roth, F. D., Aoki, A. (2005). Soluble P-Cadherin Found in Human Semen. J Androl 26: 44-47 [Abstract] [Full Text]  
  • Turner, M. S., Hafner, L. M., Walsh, T., Giffard, P. M. (2004). Identification and Characterization of the Novel LysM Domain-Containing Surface Protein Sep from Lactobacillus fermentum BR11 and Its Use as a Peptide Fusion Partner in Lactobacillus and Lactococcus. Appl. Environ. Microbiol. 70: 3673-3680 [Abstract] [Full Text]  
  • George, S. R., Ng, G. Y. K., Lee, S. P., Fan, T., Varghese, G., Wang, C., Deber, C. M., Seeman, P., O'Dowd, B. F. (2003). Blockade of G Protein-Coupled Receptors and the Dopamine Transporter by a Transmembrane Domain Peptide: Novel Strategy for Functional Inhibition of Membrane Proteins in Vivo. J. Pharmacol. Exp. Ther. 307: 481-489 [Abstract] [Full Text]